← Evidence map

TrialProgress in neuro-psychopharmacology & biological psychiatry2012

Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.

R De La Garza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22230648